Ye Weiguo
SEC CIK 1985496 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | COO | 703.0K | — | $869.9K | 18 | 2025-03-24 | 2026-06-11 |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-06-22 16:02 | 2026-06-09+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +11.0K | 703.0K | +2% | +$8,250 |
| DM | 2026-06-22 16:02 | 2026-06-09+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.25 | -11.0K | 700.0K | -2% | -$68.7K |
| D | 2026-06-15 16:01 | 2026-06-11 | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +2,800 | 702.8K | +0.4% | +$2,100 |
| D | 2026-06-15 16:01 | 2026-06-11 | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.17 | -2,800 | 700.0K | -0.4% | -$17.3K |
| DM | 2026-06-11 16:01 | 2026-06-09+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +20.9K | 706.4K | +3% | +$15.7K |
| DM | 2026-06-11 16:01 | 2026-06-09+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.16 | -20.9K | 700.0K | -3% | -$128.9K |
| DM | 2026-06-08 16:01 | 2026-06-04+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +35.0K | 715.4K | +5% | +$26.2K |
| DM | 2026-06-08 16:01 | 2026-06-04+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.25 | -35.0K | 700.0K | -5% | -$218.6K |
| DM | 2026-05-27 16:01 | 2026-05-22+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +7,500 | 704.0K | +1% | +$5,625 |
| DM | 2026-05-27 16:01 | 2026-05-22+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.09 | -7,500 | 700.0K | -1% | -$45.7K |
| DM | 2026-05-22 18:19 | 2026-05-20+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +22.2K | 712.8K | +3% | +$16.7K |
| DM | 2026-05-22 18:19 | 2026-05-20+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.15 | -22.2K | 700.0K | -3% | -$136.7K |
| DM | 2026-05-20 16:01 | 2026-05-18+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +9,320 | 709.1K | +1% | +$6,990 |
| DM | 2026-05-20 16:01 | 2026-05-18+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.38 | -9,320 | 700.0K | -1% | -$59.4K |
| DM | 2026-05-18 16:01 | 2026-05-14+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +28.7K | 713.1K | +4% | +$21.5K |
| DM | 2026-05-18 16:01 | 2026-05-14+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | S - Sale+OE | $6.79 | -28.7K | 700.0K | -4% | -$194.8K |
| D | 2025-05-14 | 2025-04-01 | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +50.0K | 700.0K | +8% | +$37.5K |
| DM | 2025-04-25 | 2025-03-24+ | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | COO | M - OptEx | $0.75 | +650.0K | 300.0K | New | +$487.5K |
Purchase Sale Sale after option exercise All abbreviations